Skip to main content
OpenTrials

Clinical trial condition

Relapsing Multiple Sclerosis

Explore clinical trials studying Relapsing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

69 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Multiple Sclerosis trial results

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

NCT04586010

Conditions
Relapsing Multiple Sclerosis
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Center for Neurology and Spine - Phoenix - Hunt - PPDS Phoenix, Arizona, United States
  • Profound Research, LLC Carlsbad, California, United States
View all 158 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)

NCT07211633

Conditions
Relapsing Multiple Sclerosis
Locations
  • TG Therapeutics Investigational Trial Site Banja Luka, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Bihać, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Mostar, Bosnia and Herzegovina
  • TG Therapeutics Investigational Trial Site Saravejo, Bosnia and Herzegovina
View all 48 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

NCT04586023

Conditions
Relapsing Multiple Sclerosis
Locations
  • North Central Neurology Associates Cullman, Alabama, United States
  • Xenoscience Phoenix, Arizona, United States
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Torrance, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 106 locations
View Trial Details
Active, not recruiting

An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis

NCT06617793

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Montpellier, France
  • Novartis Investigative Site Nancy, France
View all 18 locations
View Trial Details
Active, not recruiting

A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)

NCT05119569

Conditions
Relapsing Multiple Sclerosis
Locations
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Cleveland Clinic Lou Ruvo Las Vegas, Nevada, United States
  • University Clinical Centre of the Republic of Srpska Banja Luka, Bosnia and Herzegovina
  • Clinical Hospital Center Rijeka - PPDS Rijeka, Croatia
View all 17 locations
View Trial Details
Active, not recruiting

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

NCT05156281

Conditions
Charcot-Marie-Tooth disease, Type 1F, Disease Attributes, Pathologic Processes, +3 more
Locations
  • Ctr for Neurology and Spine Phoenix, Arizona, United States
  • Vladimir Royter MD APMC Hanford, California, United States
  • VA Greater LA Healthcare System Los Angeles, California, United States
  • Regina Berkovich MD PhD Inc West Hollywood, California, United States
View all 223 locations
View Trial Details
Active, not recruiting

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

NCT05147220

Conditions
Charcot-Marie-Tooth disease, Type 1F, Disease Attributes, Pathologic Processes, +3 more
Locations
  • AZ Integrated Neuro and Spine Phoenix, Arizona, United States
  • Center for Neurosciences Tucson, Arizona, United States
  • The Belinga Clinic Fort Smith, Arkansas, United States
  • The Research and Education Inst of Alta Bates Summit Med Grp Berkeley, California, United States
View all 200 locations
View Trial Details
Active, not recruiting

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT06372145

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • The University of Alabama at Birmingham- Site Number : 8400013 Birmingham, Alabama, United States
  • ~North Central Neurology Associates, PC- Site Number : 8400009 Cullman, Alabama, United States
  • Center for Neurology and Spine- Site Number : 8400089 Phoenix, Arizona, United States
  • Collaborative Neuroscience Research- Site Number : 8400045 Los Alamitos, California, United States
View all 352 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

NCT07483450

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University First Hospital Beijing, China
  • Beijing Hospital of Ministry of Health Beijing, China
View all 17 locations
View Trial Details

Related conditions